Exploiting human Tregs’ sweet tooth to improve cancer immunotherapy

Research output: Contribution to journalArticle

Abstract

TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.

Original languageEnglish (US)
JournalScience Translational Medicine
Volume10
Issue number466
DOIs
StatePublished - Nov 7 2018

Fingerprint

Regulatory T-Lymphocytes
Immunotherapy
Glucose
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Exploiting human Tregs’ sweet tooth to improve cancer immunotherapy. / Zeng, Hu.

In: Science Translational Medicine, Vol. 10, No. 466, 07.11.2018.

Research output: Contribution to journalArticle

@article{fb7cd5a9f5914c11984110188646a2d5,
title = "Exploiting human Tregs’ sweet tooth to improve cancer immunotherapy",
abstract = "TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.",
author = "Hu Zeng",
year = "2018",
month = "11",
day = "7",
doi = "10.1126/scitranslmed.aav6058",
language = "English (US)",
volume = "10",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "466",

}

TY - JOUR

T1 - Exploiting human Tregs’ sweet tooth to improve cancer immunotherapy

AU - Zeng, Hu

PY - 2018/11/7

Y1 - 2018/11/7

N2 - TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.

AB - TLR8 activation enhances cancer immunotherapy by reprograming of glucose metabolism in regulatory T cells.

UR - http://www.scopus.com/inward/record.url?scp=85056356179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056356179&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aav6058

DO - 10.1126/scitranslmed.aav6058

M3 - Article

AN - SCOPUS:85056356179

VL - 10

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 466

ER -